TELOMEREX
Live / Applied — Second extension granted (statement of use) (as of 05 Jan 2026)
What this means for you
Not registered yet, but its 15 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98499583
- Mark type
- Stylized text
- Filed
- 15 Apr 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Khanh T. Glatzel
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating or preventing diseases and conditions related to short telomeres
- Class 005 — Pharmaceuticals: Nutraceuticals for the treatment of or prevention of diseases and conditions related to short telomeres; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions related to short telomeres
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
Owner
- Rejuvenation Technologies Inc., Mountain View, CA, US
- Rejuvenation Technologies Inc., Mountain View, CA, US
Prosecution history
- 06 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Jan 2026 — SOU EXTENSION 2 GRANTED
- 05 Jan 2026 — SOU EXTENSION 2 FILED
- 05 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2025 — SOU EXTENSION 1 GRANTED
- 06 Jul 2025 — SOU EXTENSION 1 FILED
- 03 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Aug 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 11 Aug 2025 — NOTICE OF REVIVAL - E-MAILED
- 11 Aug 2025 — PETITION TO REVIVE-GRANTED
- 11 Aug 2025 — TEAS PETITION TO REVIVE RECEIVED
- 11 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED